Acute and Subclinical Myocardial Injury in COVID-19
References
- Jhu.org [Internet]. Baltimore, MD: Johns Hopkins University & Medicine; c2021.
Coronavirus resource center: COVID-19 United States Cases by County ; 2021 Dec 1 [cited 2021 Dec 1]. Available from:https://coronavirus.jhu.edu/us-map - Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239–1242. doi: 10.1001/jama.2020.2648
- Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020 May 19;141(20):1648–1655. doi: 10.1161/CIRCULATIONAHA.120.046941
- Azevedo RB, Botelho BG, Hollanda JVGd, et al. Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. 2021 Jan;35(1):4–11. doi: 10.1038/s41371-020-0387-4
- Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19. J Infect. 2020 Jun;80(6):607–613. doi: 10.1016/j.jinf.2020.03.037
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020 Jul;38(7):1504–1507. doi: 10.1016/j.ajem.2020.04.048
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271–280.e8. doi: 10.1016/j.cell.2020.02.052
- Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May;17(5):259–260. doi: 10.1038/s41569-020-0360-5
- Al-Amoodi M, Rao K, Rao S, Brewer JH, Magalski A, Chhatriwalla AK. Fulminant Myocarditis Due to H1N1 Influenza. Circ Heart Fail. 2010 May;3(3):e7–e9. doi: 10.1161/CIRCHEARTFAILURE.110.938506
- Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. Jan–Feb 2016;36(1):78–80. doi: 10.5144/0256-4947.2016.78
- Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009 Jul;39(7):618–25. doi: 10.1111/j.1365-2362.2009.02153.x
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052–2059. doi: 10.1001/jama.2020.6775
- Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020 Aug;81(2):e16–e25. doi: 10.1016/j.jinf.2020.04.021
- Jain S, Chaves SS. Obesity and influenza. Clin Infect Dis. 2011 Sep;53(5):422–4. doi: 10.1093/cid/cir448
- Hendren NS, de Lemos JA, Ayers C, et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Circulation. 2021 Jan 12;143(2):135–144. doi: 10.1161/CIRCULATIONAHA.120.051936
- Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003 Aug;58(8):686–9. doi: 10.1136/thorax.58.8.686
- Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020 Jun 18;382(25):e102. doi: 10.1056/NEJMoa2007621
- Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1;5(7):811–818. doi: 10.1001/jamacardio.2020.1017
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1;5(7):802–810. doi: 10.1001/jamacardio.2020.0950
- Metkus TS, Sokoll LJ, Barth AS, et al. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021 Feb 9;143(6):553–565. doi: 10.1161/CIRCULATIONAHA.120.050543
- Giustino G, Croft LB, Stefanini GG, et al. Characterization of Myocardial Injury in Patients With COVID-19. J Am Coll Cardiol. 2020 Nov 3;76(18):2043–2055. doi: 10.1016/j.jacc.2020.08.069
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
- Han H, Xie L, Liu R, et al. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J Med Virol. 2020 Jul;92(7):819–823. doi: 10.1002/jmv.25809
- Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966
- Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar 17;323(11):1061–1069. doi: 10.1001/jama.2020.1585
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. 2020 Mar 28;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
- Harris JE, Shah PJ, Korimilli V, Win H. Frequency of troponin elevations in patients with influenza infection during the 2017-2018 influenza season. Int J Cardiol Heart Vasc. 2019 Jan 30;22:145–147. doi: 10.1016/j.ijcha.2018.12.013
- Riski H, Hovi T, Frick M H. Carditis associated with coronavirus infection. Lancet. 1980 Jul 12;2(8185):100–1. doi: 10.1016/S0140-6736(80)92989-X
- Trachtenberg BH, Hare JM. Inflammatory Cardiomyopathic Syndromes. Circ Res. 2017 Sep 15;121(7):803–818. doi: 10.1161/CIRCRESAHA.117.310221
- Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020 May;22(5):911–915. doi: 10.1002/ejhf.1828
- Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovas Pathol. Jan–Feb 2021;50:
107300 . doi: 10.1016/j.carpath.2020.107300 - Kawakami R, Sakamoto A, Kawai K, et al. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 Jan 26;77(3):314–325. doi: 10.1016/j.jacc.2020.11.031
- Lindner D, Fitzek A, Bräuninger H, et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020 Nov 1;5(11):1281–1285. doi: 10.1001/jamacardio.2020.3551
- Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018 Dec 18;72(24):3158–3176. doi: 10.1016/j.jacc.2018.09.072
- Huang L, Zhao P, Tang D, et al. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging. JACC Cardiovasc Imaging. 2020 Nov;13(11):2330–2339. doi: 10.1016/j.jcmg.2020.05.004
- Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 Nov 1;5(11):1265–1273. doi: 10.1001/jamacardio.2020.3557
- Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021 Jan 7;31:
100683 . doi: 10.1016/j.eclinm.2020.100683 - Joy G, Artico J, Kurdi H, et al. Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers. JACC Cardiovasc Imaging. 2021 May 5;S1936-878X(21)00356-9. doi: 10.1016/j.jcmg.2021.04.011
- Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging. JAMA Cardiol. 2021 Aug 1;6(8):945–950. doi: 10.1001/jamacardio.2020.7444
- Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021 Sep 1;6(9):1078–1087. doi: 10.1001/jamacardio.2021.2065
- Martinez MW, Tucker AM, Bloom OJ, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiol. 2021 Jul 1;6(7):745–752. doi: 10.1001/jamacardio.2021.0565
- Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021 May 14;42(19):1866–1878. doi: 10.1093/eurheartj/ehab075
- Rajpal S, Tong MS, Borchers J, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021 Jan 1;6(1):116–118. doi: 10.1001/jamacardio.2020.4916
- Knight DS, Kotecha T, Razvi Y, et al. COVID-19: Myocardial Injury in Survivors. Circulation. 2020 Sep 15;142(11):1120–1122. doi: 10.1161/CIRCULATIONAHA.120.049252
- Kim JH, Levine BD, Phelan D, et al. Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play. JAMA Cardiol. 2021 Feb 1;6(2):219–227. doi: 10.1001/jamacardio.2020.5890
- Madjid M, Miller CC, Zarubaev V, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J. 2007 May;28(10):1205–10. doi: 10.1093/eurheartj/ehm035
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020 Jul 1;5(7):831–840. doi: 10.1001/jamacardio.2020.1286
- Cowan LT, Lutsey PL, Pankow JS, Matsushita K, Ishigami J, Lakshminarayan K. Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study. J Am Heart Assoc. 2018 Nov 20;7(22):
e009683 . doi: 10.1161/JAHA.118.009683 - Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med. 2018 Jan 25;378(4):345–353. doi: 10.1056/NEJMoa1702090
- Musher DM, Abers MS, Corrales-Medina VF. Acute Infection and Myocardial Infarction. N Engl J Med. 2019 Jan 10;380(2):171–176. doi: 10.1056/NEJMra1808137
- Kite TA, Ludman PF, Gale CP, et al. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol. 2021 May 25;77(20):2466–2476. doi: 10.1016/j.jacc.2021.03.309
- Choudry FA, Hamshere SM, Rathod KS, et al. High Thrombus Burden in Patients With COVID-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020 Sep 8;76(10):1168–1176. doi: 10.1016/j.jacc.2020.07.022
- Sama IE, Ravera A, Santema BT, et al. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020 May 14;41(19):1810–1817. doi: 10.1093/eurheartj/ehaa373
- Bhatt AS, Jering KS, Vaduganathan M, et al. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail. 2021 Jan;9(1):65–73. doi: 10.1016/j.jchf.2020.11.003
- Castagna F, Kataria R, Madan S, et al. A History of Heart Failure Is an Independent Risk Factor for Death in Patients Admitted with Coronavirus 19 Disease. J Cardiovasc Dev Dis. 2021 Jun 30;8(7):77. doi: 10.3390/jcdd8070077
- Templin C, Ghadri JR, Diekmann J, et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015 Sep 3;373(10):929–38. doi: 10.1056/NEJMoa1406761
- Chao C, DeValeria PA, Sen A, et al. Reversible cardiac dysfunction in severe COVID-19 infection, mechanisms and case report. Echocardiography. 2020 Sep;37(9):1465–1469. doi: 10.1111/echo.14807
- Dave S, Thibodeau JT, Styrvoky K, Bhatt SH. Takotsubo Cardiomyopathy in a Coronavirus Disease-2019-Positive Patient: A Case Report. A A Pract. 2020 Sep;14(11):
e01304 . doi: 10.1213/XAA.0000000000001304 - Moady G, Atar S. Takotsubo syndrome during the COVID-19 pandemic, state-of -the- art review. CJC Open. 2021 May 26. doi: 10.1016/j.cjco.2021.05.011
DOI: https://doi.org/10.14797/mdcvj.1038 | Journal eISSN: 1947-6108
Language: English
Page range: 22 - 30
Submitted on: Sep 14, 2021
Accepted on: Oct 11, 2021
Published on: Dec 15, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2021 Valentina L. Crudo, Ahmed I. Ahmed, Eilidh L. Cowan, Dipan J. Shah, Mouaz H. Al-Mallah, Maan Malahfji, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.